Dr. Achim Battmann, head of pathology at the Nordwest Krankenhaus in Frankfurt, Germany, describes how NGS has changed the way oncology research is done and how the results impact tumor diagnostics.
In the service of life
Dr. Achim Battmann has been head of the Institute of Pathology and Cell Diagnostics at the Tumor Center at Nordwest Krankenhaus Frankfurt since 2014.
GeneReader NGS System
The world's first truly complete next-generation sequencing (NGS) workflow takes labs from raw samples all the way to actionable insights in record time to ensure results are ready when they are needed most.
founded in 1963, is a well-known hospital that houses six institutes and specializes in eleven disciplines. Today, it serves as the teaching hospital of Goethe University Frankfurt. The oncology center is certified by the German Cancer Society.
The need for information on the molecular level is growing. Machines run sequencing processes 24/7. That’s one of the reasons Battmann picked the GeneReader NGS System in 2016, a technology which he believes has made its mark on cancer research, and will continue to do so for the next 15 to 20 years. Why? “Because it gets the most comprehensive set of data you can get,” says Battmann, referring to the report generated by the system via integrated QIAGEN Clinical Insight (QCI) Interpret bioinformatics software.
The data report includes information like the kind of mutation, and the potential pathogenic impact of the mutation on the disease. “And if you want to dive further into this, it seems like there is always a list of citations on everything.”
These vast amounts of data have given rise to another issue that is gaining importance. Battmann calls it “a controlled reproducible workflow”. One of the QIAGEN GeneReader NGS System’s most important benefits is its ability to bundle the whole process in a single workflow, because switching between systems can spur mistakes.
Besides the workflow, QIAGEN’s service swayed him: “The most advanced instrument is of no use if there is no service provided.” Battmann's experience with QIAGEN is: “They meet all our demands. We just order the things, and they come. If there’s a problem we call and it’s taken care of.”